Studies evaluating pharmacological interventions to prevent T2D in women with previous GDM have shown some benefits with a range of drug classes including metformin, thiazolidinediones, incretins and dipeptidyl peptidase-4 inhibitors.9 This evidence concerns the gene GCG and type 2 diabetes mellitus.